Concentration and Time Dependent Growth Inhibition and Metabolism in vitro by 2’,2’-Difluoro-Deoxycytidine (Gemcitabine)
Authors:
- 1 January 1991
- book chapter
- Published by Springer Nature
- p. 57-60
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Comparison of the sulforhodamine B protein and tetrazolium (MTT) assays for in vitro chemosensitivity testingEuropean Journal of Cancer and Clinical Oncology, 1991
- New Colorimetric Cytotoxicity Assay for Anticancer-Drug ScreeningJNCI: Journal of the National Cancer Institute, 1990
- Retention of in vivo antipyrimidine effects of brequinar sodium (DUP-785; NSC 368390) in murine liver, bone marrow and colon cancerBiochemical Pharmacology, 1990
- Patient-specific dose rate for continuous infusion high-dose cytarabine in relapsed acute myelogenous leukemia.Journal of Clinical Oncology, 1989
- 2',2'-Difluorodeoxycytidine Metabolism and Mechanism of Action In Human Leukemia CellsNucleosides, Nucleotides & Nucleic Acids, 1989
- Chapter 3. Anti-Growth Effects1986
- Relationships among Ara-CTP pools, formation of (Ara-C)DNA, and cytotoxicity of human leukemic cellsBlood, 1984